| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Streptococcus (group C) |
8 |
16 |
? － ? |
Pexiganan  |
14 |
| Streptococcus (group C) |
32 |
- |
16 － 64 |
MSI-78 (Peptide) |
65 |
| Streptococcus (group C) |
64 |
64 |
64 － ? |
Tioconazole |
1504 |
| Streptococcus (group C) |
500 |
- |
>500 － ? |
Kasugamycin |
1431 |
| Streptococcus (group D) |
0.12 |
0.25 |
≤0.016 － 2 |
Tigecycline (GAR-936, Tigacyl) |
472 |
| Streptococcus (group D) |
>0.5 |
>16 |
≤0.12 － >16 |
Teicoplanin (Targocid) |
472 |
| Streptococcus (group D) |
1 |
4 |
0.03 － 8 |
Daptomycin (Cubicin) |
472 |
| Streptococcus (group D) |
>1 |
>16 |
0.25 － >16 |
Vancomycin (Vancocyn, Lyphocin) |
472 |
| Streptococcus (group D) |
>2 |
>2 |
≤0.25 － >2 |
Quinupristin/Dalfopristin (Synercid) |
472 |
| Streptococcus (group D) |
2 |
2 |
0.25 － >8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
472 |
| Streptococcus (group D) |
>2 |
>16 |
0.25 － >16 |
Ampicillin (Omnipen) |
472 |
| Streptococcus (group D) |
>4 |
>4 |
0.06 － >4 |
Levofloxacin (Levaquin, Quixin) |
472 |
| Streptococcus (group D) |
>8 |
>8 |
≤2 － >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
472 |
| Streptococcus (group D) |
>500 |
>1000 |
≤500 － >1000 |
Gentamicin (Gentamycin, Garamycin) |
472 |
| Streptococcus (group D) |
500 |
- |
>500 － ? |
Kasugamycin |
1431 |
| Streptococcus (group D) |
>1000 |
>2000 |
≤1000 － >2000 |
Streptomycin |
472 |
| Streptococcus (group F) |
0.06 |
0.12 |
? － ? |
Clinafloxacin (PD 127391) |
307 |
| Streptococcus (group F) |
0.5 |
1 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
307 |
| Streptococcus (Group G + clinical isolate) |
- |
- |
32 － ? |
RRP9W4N |
1361 |
| Streptococcus (group G + erythromycin-susceptible) |
0.031 |
0.031 |
≤0.008 － 0.031 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
502 |
| Streptococcus (group G + erythromycin-susceptible) |
0.031 |
0.063 |
≤0.031 － 0.025 |
Spiramycin |
502 |
| Streptococcus (group G + erythromycin-susceptible) |
0.031 |
0.063 |
≤0.031 － 0.25 |
Clarithromycin (Biaxin) |
502 |
| Streptococcus (group G + erythromycin-susceptible) |
0.063 |
0.063 |
0.063 － 0.25 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
502 |
| Streptococcus (group G + erythromycin-susceptible) |
0.063 |
0.125 |
≤0.031 － 0.25 |
Clindamycin (Cleocin) |
502 |
| Streptococcus (group G + erythromycin-susceptible) |
0.125 |
0.125 |
0.125 － 1 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
502 |
| Streptococcus (group G + erythromycin-susceptible) |
1 |
1 |
0.5 － 1 |
Quinupristin/Dalfopristin (Synercid) |
502 |
| Streptococcus (group G + inducible erm(TR)) |
0.063 |
0.063 |
0.031 － 0.063 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
502 |
| Streptococcus (group G + inducible erm(TR)) |
0.125 |
0.5 |
0.063 － 0.5 |
Clindamycin (Cleocin) |
502 |